News | Heart Failure | October 05, 2022

American Society of Echocardiography Invests in Joint Research Initiative to Help Patients Suffering from Wide-Reaching Form of Heart Failure

The American Society of Echocardiography (ASE) is targeting its research funding over the next five years to help solve some of the mysteries around the early detection of a common form of heart failure.

Getty Images


October 5, 2022 —  The American Society of Echocardiography (ASE) is targeting its research funding over the next five years to help solve some of the mysteries around the early detection of a common form of heart failure. ASE is one of the key partner organizations in a joint research initiative that aims to identify more precise treatment strategies for patients suffering from heart failure with preserved ejection fraction (HFpEF). 

The Accelerating Medicines Partnership Heart Failure (AMP HF) Program will utilize more than $37 million in funding from private and public collaborators—which includes ASE—to better diagnose and develop treatment options for HFpEF and improve the outlook for millions of patients around the world. The Foundation for the National Institutes of Health (FNIH) and the National Heart Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH) will facilitate the program over the next five years. 

“One of ASE’s current strategic goals is to focus our efforts where they are most needed,” says Stephen H. Little, MD, FASE, FRCPC, FACC, ASE’s 2022-2023 Board of Directors President. “The Society is proud to support research projects like AMP HF because of the great promise the findings can have in advancing the field of cardiovascular ultrasound and improving patient care.” 

HFpEF is a common form of heart failure that is difficult to detect. It is often deadly, with a five-year survival rate of just 35-40%. In addition to a high risk for mortality, patients with HFpEF live with declining quality of life and poor capacity to perform tasks of daily living. 

The AMP HF Program will advance the understanding of HFpEF using two complementary and integrated research components: analyzing existing HFpEF datasets, sourced from public and private sector funded studies, and initiating a new clinical trial to confirm retrospective findings in an observational cohort with a goal to develop a framework for new precision treatments. 

“Echocardiography is a specialty that already plays a significant role in diagnosing heart conditions, and we look forward to continuing to learn how echocardiographic screenings can be used in understanding the many still unanswered questions about HFpEF,” says Judy Hung, MD, FASE, who is a cardiologist with Massachusetts General Hospital and an ASE past president. 

“Research shapes the future of medicine, and ASE is honored to be among some of the largest and most innovative biomedical partners contributing to this important initiative,” Dr. Hung added. 

ASE’s charitable arm, the ASE Foundation, provides support for initiatives that are not funded by membership dues—such as training scholarships and scientific research. In the last 25 years, the Society and its Foundation have contributed more than $7.3 million to cardiovascular health research. 

For more information: www.asecho.org 


Related Content

News | ASE

June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help ...

Home June 12, 2024
Home
Feature | ASE | Christine Book

June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific ...

Home June 04, 2024
Home
News | ASE

July 5, 2023 — Research presented during the American Society of Echocardiography’s 34th Annual Scientific Sessions, ASE ...

Home July 05, 2023
Home
News | ASE

June 29, 2023 — At the conclusion of the American Society of Echocardiography 2023 Scientific Sessions, ASE 2023, the ...

Home June 29, 2023
Home
News | ASE

June 29, 2023 — A large, multi-center study presented during the American Society of Echocardiography’s (ASE) 34th ...

Home June 29, 2023
Home
Feature | ASE | Christine Book

June 27, 2023 — The 2023 American Society of Echocardiography Scientific Sessions, ASE 2023, “Foundations and the future ...

Home June 27, 2023
Home
News | ASE

June 23, 2023 — Building on its established leadership in cardiovascular ultrasound, Philips will showcase its ...

Home June 23, 2023
Home
News | ASE

June 13, 2023 — Core Sound Imaging, Inc. has announced the introduction of the Studycast Integration Program. The ...

Home June 13, 2023
Home
News | ASE
May 5, 2022 – The American Society of Echocardiography (ASE), the largest global organization for cardiovascular ...
Home May 05, 2022
Home
News | ASE
April 21, 2022 – The American Society of Echocardiography (ASE) is pleased to announce that its membership has elected ...
Home April 21, 2022
Home
Subscribe Now